Navigation Links
TriReme Announces Signing of a Master Distribution Agreement in China

PLEASANTON, Calif. and SINGAPORE, March 26, 2013 /PRNewswire/ -- TriReme Medical, Inc. and its affiliates (TriReme) announced today that it has signed a comprehensive agreement with Weihai Weigao Medical Devices, Ltd for the distribution of its products in the People's Republic of China. Weigao will act as TriReme's master distributor by selling TriReme products directly to hospitals as well as connecting TriReme products into its vast nationwide distribution network. This agreement complements TriReme's strategy of focusing on Asia, the fastest growing market in interventional cardiology.

"Due to many factors including increased affordability, aging population and an increase in the number of state-of-the-art medical facilities, China has become the world's second largest market in terms of the volume of interventional coronary vascular procedures," stated Eitan Konstantino Ph.D, CEO and President of TriReme. "For similar reasons, we expect that the number of peripheral vascular procedures will rise dramatically in the coming years to the point where China becomes the world's largest market in terms of total vascular interventions."

Ms CHU Swee Yeok, CEO and President, EDBI and Bio*One Capital said: "We are confident that TriReme products and technologies will lead to better clinical outcomes for Chinese patients and are thrilled to partner with a distinguished player like Weigao to introduce TriReme products into the world's fastest growing healthcare market. Such a partnership is a great example of how highly innovative companies like TriReme can leverage on Singapore as a base to access vital Asia markets for their growth."

"Weigao remains committed to partnering with healthcare providers across China to provide access to best-in-class technology across a wide range of product categories," explained Mr SUN Feng Wei, General Manager of Weigao Medical Devices, Ltd. "We view TriReme as a top brand and this partnership allows us to bring the highest quality devices to our growing customer base of physicians performing interventional vascular procedures."

About TriReme Medical, Inc.

Based in Singapore and Pleasanton, California, TriReme Medical, Inc. is a privately held medical device company dedicated to the development, manufacturing, and commercialization of next generation percutaneous devices for the treatment of complex coronary and peripheral arterial disease. The company is focused on the US and the emerging Asian markets.

About Weigao

Based in Weihai, China and publicly traded on the Hong Kong Stock exchange (Stock Code: 1066), Weigao manufactures and sells over 100 types of products, including disposable medical consumables, orthopedic materials and tools, medical needles, blood purification consumables, and interventional cardiology devices. It maintains a vast distribution network of 24 regional sales offices, 30 customer service centers, 100 municipal representatives, and 1200 sales representatives. It sells to over 2700 hospitals, 400 blood stations, and over 1500 distribution/trading partners across China.

SOURCE TriReme Medical, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. TriReme Announces a New Round of Financing Totalling US$18 Million
2. TriReme Medical, Inc. Receives FDA Approval for Glider™ PTCA Catheter
3. Genalyte Announces CE Mark For Maverick(TM) Detection System And Signs On First European Distributors
4. Omeros Announces Successful Completion of PDE10 Phase 1 Multiple Ascending Dose Trial
5. ECRI Institute Announces 2013 Health Devices Achievement Award -- Call for Entries
6. ULURU Inc. Announces Conference Call to Discuss Financial Results for the Fourth Quarter and Year Ended December 31, 2012 and to Provide a Business Update
7. Research and Markets Announces The Release of Neuromodulation Market - Forecasts to 2017
8. SARcode Bioscience Announces Acquisition by Shire US Holdings Inc.
9. Creative Edge Nutrition, Inc. Announces the Entrance into the Medical Marijuana Sector
10. arGEN-X Announces Preclinical Development of ARGX-112 for Dermatology
11. United Therapeutics Announces Receipt Of Second Complete Response Letter For Oral Treprostinil NDA
Post Your Comments:
(Date:12/1/2015)... 1, 2015 /PRNewswire/ -- Royal Philips  ... an X-ray imaging software that produces high-contrast images for ... use a grid, at the 2015 Radiological Society ... SkyFlow is Philips, first digital imaging solution providing grid-like ... improves clinician,s workflow and supports "first-time-right imaging" by decreasing ...
(Date:12/1/2015)... , Dec. 1, 2015  Athletic apparel company ... have agreed to pay $1.35 million to settle ... the company,s copper-infused compression clothing would relieve severe ... and other diseases. Tommie Copper,s ... the company and its founder and chairman ...
(Date:12/1/2015)... 2015  AccuTEC Blades, a leader in precision ... and brand identity program. The new logo underscores ... bladed products where "the edge makes all the ... Serving manufacturers and distributors of medical, food ... AccuTEC,s product lines include those acquired when AccuTEC  ...
Breaking Medicine Technology:
(Date:12/1/2015)... ... 01, 2015 , ... Trustify is proud to announce the success of the ... an organization dedicated to ending domestic violence. , Trustify and Becky’s Fund have joined ... survivors of domestic violence. Trustify is also proud to announce the launch of the ...
(Date:12/1/2015)... ... December 01, 2015 , ... Henderson, a town of ... Gigabit Internet through a partnership this year with Aeneas Internet and Telephone. , ... attractive destination for entrepreneurs who want to build a business. Whether startups or ...
(Date:12/1/2015)... Angeles, CA (PRWEB) , ... December 01, 2015 , ... ... coalition of obesity groups has filed a discrimination claim against the U.S. Department of ... coverage in their Affordable Care Act (ACA) plans are breaking the clause in the ...
(Date:12/1/2015)... ... December 01, 2015 , ... Speech and physical therapies are ... innovative technologies and under the right circumstances, these practices can be merged. ... dual-approach to his or her therapeutic sessions, as well as gives the physical ...
(Date:12/1/2015)... , ... December 01, 2015 , ... It’s official: Tattoo ... tattoo — a number even greater among Millennials (a whopping one in three aged ... and more people who are dissatisfied with their ink. In fact, RealSelf , ...
Breaking Medicine News(10 mins):